Loading…
Reported covered position: Legislative Assistant, Office of Senator Mike Crapo; September 2003-November 2007
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2026 · third_quarter · Q3
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling National Defense Authorization Act (NDAA)
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2026 · second_quarter · Q2
Source: Senate LDA
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines. Issues pertaining to controlled substances rescheduling
Filing targets: Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2026 · first_quarter · Q1
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2025 · fourth_quarter · Q4
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2025 · third_quarter · 3A
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2025 · third_quarter · Q3
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2025 · second_quarter · Q2
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPASS PATHWAYS INC. via COMPASS PATHWAYS INC.
2025 · second_quarter · RR
Legislative and regulatory issues pertaining to the use and application of psychedelic medicines
Legislative and regulatory issues pertaining to the use and application of psychedelic medicines
Legislative and regulatory issues pertaining to the use and application of psychedelic medicines